®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
November 13, 2015
Bloom Burton’s analyst David Martin speaks to BNN about Concordia's sell-off and the future of biotech in Canada
Click on the image to view the full video.
RELATED NEWS
See All News
Roberto Bellini Receives the 2024 Bloom Burton Award
The Globe and Mail | Ex-Chinook team launches Borealis Biosciences with $150-million from Novartis, Versant
Hamilton City Magazine | Coming to life at McMaster University
Acquisition of Fusion Pharmaceuticals Completed
Three Finalists Announced for the 2024 Bloom Burton Award
The Globe and Mail | LSD, Ecstasy, magic mushrooms coming to a clinic near you? Legalization nears for psychedelics
Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader
Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million
The Globe and Mail | AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion
The Globe and Mail | Vancouver readies for its position as a global pharma capital as B.C.’s biotech boom takes off
Click on the image to view the full video.
